Ферротерапия железодефицитных анемий у детей
DOI:
https://doi.org/10.15574/SP.2016.75.58Ключевые слова:
железодефицитное состояние, дети, ферротерапия, препараты ГПК Fe3Аннотация
Данная статья посвящена шагам по имплементации Унифицированного клинического протокола первичной, вторичной (специализированной) медицинской помощи «Железодефицитная анемия» в практическую деятельность педиатров, семейных врачей, а именно особенностям ферротерапии у детей разных возрастных групп, вопросам профилактики железодефицитных состояний.
Ключевые слова: железодефицитное состояние, дети, ферротерапия, препараты ГПК Fe3+.
Библиографические ссылки
Anemii u detey: diagnostika i lechenie. Prakticheskoe posobie dlya vrachey. Pod red A Rumyantseva, YuN Tokareva. Moskva, MAKS-Press, 2000: 492.
Zalizodefitsytna anemiia. Adaptovana klinichna nastanova, zasnovana na dokazakh. 2015. www.moz.gov.ua/docfiles/dn_20151102_0709dod_ukp.pdf — Назва з екрану.
Zaharova IN, Dmitrieva YuA. 2011.Sindrom anemii v praktike pediatra: differentsialnaya diagnostika i terapiya. EF. Pediatriya. 3. http://medi.ru.
Korneva VV. 2015. Mediko-sotsialnyie posledstviya defitsita zheleza u detey. Sovremennaya pediatriya. 1: 101—105.
Korneva VV. 2013. Optimalnyiy vyibor preparatov zheleza v lechenii zhelezodefitsitnoy anemii detey. Sovremennaya pediatriya. 4: 45—50.
Hoida NH, Moiseienko RO, Chernyshova LI et al. 2013. Pediatriia. Natsionalnyi pidruchnyk. U 2 t. Za red VV Berezhnoho; Asotsiatsiia pediatriv Ukrainy. Kyiv, Storozhuk OV. 1: 1037.
Omelchenko LI, Tsyipkun AG, Dudka IV et al. 2004. Primenenie preparata FERUMBO pri zhelezodefitsitnoy anemii u detey. Mystetstvo likuvannia. 4: 13—15.
Pro zatverdzhennia somoho vypusku Derzhavnoho formuliara likarskykh zasobiv ta zabezpechennia yoho dostupnosti. Nakaz MOZ Ukrainy vid 30.03.2015 р. №183. http://www.moz.gov.ua.
Pro zatverdzhennia ta vprovadzhennia medyko-tekhnolohichnykh dokumentiv zi standartyzatsii medychnoi dopomohy pry zalizodefitsytnii anemii. Nakaz MOZ Ukrainy №709 vid 02.11.2015 r. http://www.moz.gov.ua.
Almache ON, Del Aguila CM. 2005. Controlled study of two compounds of ferric polymaltose in the treatment of iron deficiency anaemia in children aged between 6 months and 2 years. Journal of the Anaemia Working Group Latin America (AWGLA). 1: 31—38.
Baker RD, Greer FR. 2010. Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0–3 years of age). Pediatrics. 126(5): 1040—1050.
Domellоf M, Dewey KG, Lonnerdal В. 2002. The diagnostic criteria for iron deficiency in infants should be reevaluated. J Nutr. 132(12): 3680—3686.
EMEA, The rules governing medicinal products in the European Union. Investigation of Bioavailability and Bioequivalence. 1998. 3C: 231—244.
FDA, Electronic Orange Book. Approved Drug Products with Therapeutic Equivalence Evaluations. 20th Edition, 2000: 62.
Geisser P. 2004. Iron therapy, oxidative stress and immunology. Nutrition and Immunology in the 21st century. Chandra RK (Ed). India, TSAR Health: 54—65.
Geisser P. 2007. Safety and efficacy of iron(III)(hydroxide polymaltose complex / a review of over 25 years experience. Arzneimittel for schung. 57: 439—452.
Hallberg L, Hulthen L. 2006. Erratum concerning the article «Prediction of dietary iron absorption: an algorithm for calculating absorption and bioavailability of dietary iron». Am J Clin Nutr. 84: 1253.
http://www.dec.gov.ua/mtd/reestr.html
Booze LL et al. 2005. Iron Deficiency Anaemia: Assessment, Prevention, and Control. A guide for 20. Iron ingestion: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila). 4: 553—570.
Jacobs P, Wood I, Bird AR. 2000. Better tolerance of iron polimaltose complex compared with ferrous sulfate in the treatment of anemia. Hematology. 5: 77—83.
Kavakli K. 2004. Safety profiles of Fe2+ and Fe3+ oral preparations in the treatment of iron deficiency anaemia in children. Pediatr Hematol Oncol. 21: 403—10.
Lozoff В, Beard J, Connor J et al. 2006. Long-lasting neural and behavioral effects of iron deficiency in infancy. Nutr Rev. 64: 34—43.
Madero D. 2007. Efficiency and safety of hydroxide complex ferric iron (III) and polymaltose (IPC) vs iron amino acid chelate in the management of anaemia deficiency in children. Revista del AWGLA. 3: 28—39.
Nunez O, Del Aguila CM. 2005. Controlled study of two compounds of ferric polymaltose in the treatment of iron deficiency anaemia in children aged between 6 months and 2 years. Revista del AWGLA. 1: 31—38. programme managers. — Geneva, WHO, 2001. WHO/NHD/01.3.
Recommendations to prevent and control iron deficiency with of the International Nutritional Anemia Consultative Group (INACG), WHO and UNICEF. Geneve, 2004.
Yasa B, Agaoglu L, Unuvar Е. 2011. Efficacy, tolerability, and acceptability of iron hydroxide polymaltose complex versus ferrous sulfate: a randomized trial in pediatric patients with iron deficiency anemia. Int J Pediatrics. Article ID 524520: 6.
